Stay updated on Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial
Sign up to get notified when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.

Latest updates to the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page
- Check5 days agoChange DetectedAdded a related topics block for Multiple myeloma under MedlinePlus Genetics on the study page, providing access to additional health information about the condition.SummaryDifference0.2%

- Check12 days agoChange DetectedThe related topics header and two topic entries were removed from the page, reducing the displayed connections to the study.SummaryDifference0.2%

- Check19 days agoChange DetectedAdded related-topic keywords (Multiple myeloma and MedlinePlus Genetics) and updated the site revision from v3.5.3 to v3.5.4.SummaryDifference0.2%

- Check26 days agoChange DetectedThe page's explicit disease label and related resources are removed, reducing the visible context and cross-links to genetics information on this study record.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page's revision label now shows Revision: v3.5.3, replacing Revision: v3.5.2. This reflects a new revision of the page's metadata.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.